AR066509A1 - Derivados de tiazol, medicamentos que los contienen, proceso de preparacion y usos como moduladores de beta amiloide. - Google Patents
Derivados de tiazol, medicamentos que los contienen, proceso de preparacion y usos como moduladores de beta amiloide.Info
- Publication number
- AR066509A1 AR066509A1 ARP080101972A ARP080101972A AR066509A1 AR 066509 A1 AR066509 A1 AR 066509A1 AR P080101972 A ARP080101972 A AR P080101972A AR P080101972 A ARP080101972 A AR P080101972A AR 066509 A1 AR066509 A1 AR 066509A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogen
- lower alkyl
- chr
- optionally substituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se ha descubierto que los presentes compuestos de la formula 1 son moduladores del amiloide beta y, por tanto, pueden ser utiles para el tratamiento o prevencion de una enfermedad asociada con la deposicion de beta-amiloide en el cerebro, enparticular la enfermedad de Alzheimer. Reivindicacion 1: Un compuesto de la formula general (1) en la que hetarilo 1 es como en formulas (2), hetarilo 2 es como en formulas (3), R1 es hidrogeno, alcoxi inferior o ciano; R2/R3 con independenciaentre sí son hidrogeno, alquilo inferior, alquilo inferior sustituido por halogeno, CHO, fenilo o -CRR'-fenilo, dichos anillos fenilo están sin sustituir o sustituidos por uno o más halogeno, ciano, alquilo inferior, alquilo inferior sustituido porhalogeno, alcoxi inferior sustituido por halogeno o alcoxi inferior, o son -C(O)O-alquilo inferior, -CH2-C(O)O-alquilo inferior, -CH2-C(O)-piperidin-1-ilo, -CH2-C(O)NH-alquilo inferior, -CH2-C(O)NH-fenilo opcionalmente sustituido por halogeno, -CHR-NHC(O)O-alquilo inferior, -CHR-NH, -CHR-NH-CH-fenilo opcionalmente sustituido por halogeno, -CHR-NH-(CH292-fenilo opcionalmente sustituido por halogeno, -CHR-NH-fenilo opcionalmente sustituido por halogeno, -CHR-NH-cicloalquilo, -CHR-NHC(O)-CH2-fenilo opcionalmente sustituido por halogeno, -CHR-NHC(O)-CH2O-alquilo inferior, -CHR-NHC(O)-alquilo inferior, -CHR-NHC(O)O-alquilo inferior sustituido por halogeno, -CHR-NHC(O)-fenilo opcionalmente sustituido por halogeno, -CHR-NHCH2CH2O-alquiloinferior, -CHR-NH-S(O)2-fenilo opcionalmente sustituido por halogeno o alquilo inferior, -CHR-NH-S(O)2-CH2-fenilo opcionalmente sustituido por halogeno, -CHR-NH-S(O)2-alquilo inferior, - CH2-piperidin-1-ilo, -CH2-morfolinilo o - (3,4-difluor-fenil)amida del ácido indol-2-carboxílico; R/R' con independencia entre sí son hidrogeno, alquilo inferior, bencilo o hidroxi; R4 es hidrogeno, -C(O)O-alquilo inferior, -C(O)-fenilo opcionalmente sustituido por halogeno, -C(O)-alquilo inferiorsustituido por halogeno, -C(O)-alquilo inferior, -S(O)2-fenilo opcionalmente sustituido por halogeno, -S(O)2-alquilo inferior, -S(O)2-CH2-fenilo, -bencilo opcionalmente sustituido por halogeno, -CH2-CH2-fenilo, -C(O)-CH2-fenilo opcionalmentesustituido por halogeno o -C(O)-CH2-alcoxi inferior; R5 es hidrogeno, halogeno, alquilo inferior sustituido por hidroxi, o es alquilo inferior; n es el numero 0 o 1; o sus sales de adicion de ácido farmacéuticamente activas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07108004 | 2007-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066509A1 true AR066509A1 (es) | 2009-08-26 |
Family
ID=39758855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101972A AR066509A1 (es) | 2007-05-11 | 2008-05-09 | Derivados de tiazol, medicamentos que los contienen, proceso de preparacion y usos como moduladores de beta amiloide. |
Country Status (20)
Country | Link |
---|---|
US (1) | US7910740B2 (es) |
EP (1) | EP2155740B1 (es) |
JP (1) | JP5264890B2 (es) |
KR (1) | KR101138045B1 (es) |
CN (1) | CN101675045B (es) |
AR (1) | AR066509A1 (es) |
AT (1) | ATE496915T1 (es) |
AU (1) | AU2008250436B2 (es) |
BR (1) | BRPI0811993A2 (es) |
CA (1) | CA2686754C (es) |
CL (1) | CL2008001347A1 (es) |
DE (1) | DE602008004769D1 (es) |
ES (1) | ES2358863T3 (es) |
IL (1) | IL201566A (es) |
MX (1) | MX2009012163A (es) |
PE (1) | PE20090248A1 (es) |
RU (1) | RU2009140182A (es) |
TW (1) | TW200904420A (es) |
WO (1) | WO2008138753A1 (es) |
ZA (1) | ZA200907585B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7667041B2 (en) * | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
US7923563B2 (en) * | 2004-10-26 | 2011-04-12 | Eisai R&D Management Co., Ltd. | Amorphous object of cinnamide compound |
EP1953151A4 (en) * | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF |
CA2628047A1 (en) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Process for production of cinnamide derivative |
TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
CA2629745A1 (en) * | 2005-11-24 | 2007-05-31 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
AR062095A1 (es) * | 2006-07-28 | 2008-10-15 | Eisai R&D Man Co Ltd | Profarmaco de compuesto cinamida |
KR20090082502A (ko) | 2006-12-22 | 2009-07-30 | 에프. 호프만-라 로슈 아게 | 스피로-피페리딘 유도체 |
CL2008000582A1 (es) * | 2007-02-28 | 2008-06-27 | Eisai R&D Man Co Ltd | Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis. |
JPWO2008140111A1 (ja) * | 2007-05-16 | 2010-08-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | シンナミド誘導体のワンポット製造方法 |
TW200916469A (en) | 2007-08-31 | 2009-04-16 | Eisai R & Amp D Man Co Ltd | Multi-cyclic compounds |
US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
CA2705411A1 (en) * | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Heteroaryl derivatives as orexin receptor antagonists |
RU2010132728A (ru) | 2008-01-11 | 2012-02-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Модуляторы бета-амилоида |
JPWO2009096349A1 (ja) * | 2008-01-28 | 2011-05-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 結晶性のシンナミド化合物またはその塩 |
RU2010137300A (ru) * | 2008-02-22 | 2012-03-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Модуляторы бета-амилоида |
WO2010040661A1 (en) | 2008-10-09 | 2010-04-15 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
CA2742897A1 (en) * | 2008-11-06 | 2010-05-14 | Astrazeneca Ab | Modulators of amyloid beta. |
BRPI0921348A2 (pt) * | 2008-11-10 | 2019-09-24 | Hoffmann La Roche | moduladores heterocíclicos da gama secretase |
PA8854101A1 (es) * | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
US8946426B2 (en) | 2009-02-06 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | Substituted bicyclic heterocyclic compounds as gamma secretase modulators |
TWI461425B (zh) * | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
AU2010262036B2 (en) * | 2009-05-07 | 2014-10-30 | Cellzome Limited | Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators |
UY32622A (es) * | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
MX2012000763A (es) | 2009-07-15 | 2012-02-08 | Janssen Pharmaceuticals Inc | Derivados sustituidos de triazol e imidazol como moduladores de la gamma secretasa. |
MX2012008259A (es) | 2010-01-15 | 2012-08-17 | Janssen Pharmaceuticals Inc | Novedosos derivados biciclicos de triazol sustituidos como moduladores de gamma secretasa. |
US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
CN103502225B (zh) | 2011-03-24 | 2015-11-25 | 杨森制药公司 | 作为γ分泌酶调节剂的经取代的三唑基哌嗪以及三唑基哌啶衍生物 |
ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
AU2012285931B2 (en) | 2011-07-15 | 2017-01-12 | Cellzome Limited | Novel substituted indole derivatives as gamma secretase modulators |
WO2013171712A1 (en) | 2012-05-16 | 2013-11-21 | Janssen Pharmaceuticals, Inc. | Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease |
UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
KR102209418B1 (ko) | 2012-12-20 | 2021-01-29 | 얀센 파마슈티카 엔.브이. | 감마 세크레타제 조절 인자로서의 신규 삼환 3,4-디하이드로-2H-피리도[1,2-α]피라진-1,6-디온 유도체 |
US10246454B2 (en) | 2013-01-17 | 2019-04-02 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
CN103664819A (zh) * | 2013-12-16 | 2014-03-26 | 山东汇海医药化工有限公司 | 一种2-氨基-4-甲基噻唑-5-甲酸乙酯的制备方法 |
US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
PE20171318A1 (es) | 2015-02-03 | 2017-09-07 | Pfizer | Ciclopropabenzofuranil-piridopirazindionas novedosas |
JP2019512491A (ja) * | 2016-03-11 | 2019-05-16 | エーシー・イミューン・エス・アー | 診断及び療法のための二環式化合物 |
US10647721B2 (en) * | 2016-10-04 | 2020-05-12 | Hoffmann-La Roche Inc. | Bicyclic heteroaryl derivatives |
CN110194764B (zh) * | 2018-02-26 | 2022-08-16 | 云南大学 | 酰胺类化合物、其制备方法及用途 |
CN112566696B (zh) | 2018-09-03 | 2024-01-16 | 豪夫迈·罗氏有限公司 | 双环杂芳基衍生物 |
WO2021083182A1 (zh) * | 2019-10-28 | 2021-05-06 | 南京明德新药研发有限公司 | 一种尿酸促排剂及其合成方法和其在医药上的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010082501A (ko) * | 1997-10-27 | 2001-08-30 | 개리 이. 프라이드만 | 4-아미노티아졸 유도체, 그 제조방법 및 싸이클린-의존성키나아제의 억제제로서의 이용방법 |
ATE288904T1 (de) * | 1998-06-18 | 2005-02-15 | Bristol Myers Squibb Co | Durch kohlenstoff substituierte aminothiazole als inhibitoren von zyclin-abhägigen kinasen |
WO2001087845A2 (en) * | 2000-05-15 | 2001-11-22 | Fujisawa Pharmaceutical Co., Ltd. | N-containing heterocyclic compounds and their use as 5-ht antagonists |
KR20060023529A (ko) * | 2003-05-14 | 2006-03-14 | 토레이파인스 테라퓨틱스, 인코포레이티드 | 화합물 및 아밀로이드 베타를 변조하는데 있어서 그의 용도 |
US7667041B2 (en) | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
US20080125432A1 (en) * | 2004-12-01 | 2008-05-29 | Devgen Nv | 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family |
US20060241038A1 (en) | 2005-04-20 | 2006-10-26 | Eisai Co., Ltd. | Therapeutic agent for Abeta related disorders |
CA2628047A1 (en) | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Process for production of cinnamide derivative |
EP1953151A4 (en) | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF |
CA2629745A1 (en) * | 2005-11-24 | 2007-05-31 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
US20070117839A1 (en) * | 2005-11-24 | 2007-05-24 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
EA016464B1 (ru) | 2006-03-09 | 2012-05-30 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Полициклические производные арилимидазола |
TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
-
2008
- 2008-04-30 JP JP2010507876A patent/JP5264890B2/ja not_active Expired - Fee Related
- 2008-04-30 BR BRPI0811993-7A2A patent/BRPI0811993A2/pt not_active Application Discontinuation
- 2008-04-30 AT AT08749887T patent/ATE496915T1/de active
- 2008-04-30 DE DE602008004769T patent/DE602008004769D1/de active Active
- 2008-04-30 CN CN2008800140851A patent/CN101675045B/zh not_active Expired - Fee Related
- 2008-04-30 AU AU2008250436A patent/AU2008250436B2/en not_active Ceased
- 2008-04-30 EP EP08749887A patent/EP2155740B1/en not_active Not-in-force
- 2008-04-30 MX MX2009012163A patent/MX2009012163A/es active IP Right Grant
- 2008-04-30 RU RU2009140182/04A patent/RU2009140182A/ru unknown
- 2008-04-30 KR KR1020097025780A patent/KR101138045B1/ko active IP Right Grant
- 2008-04-30 CA CA2686754A patent/CA2686754C/en not_active Expired - Fee Related
- 2008-04-30 ES ES08749887T patent/ES2358863T3/es active Active
- 2008-04-30 WO PCT/EP2008/055290 patent/WO2008138753A1/en active Application Filing
- 2008-05-05 US US12/114,852 patent/US7910740B2/en not_active Expired - Fee Related
- 2008-05-08 TW TW097117052A patent/TW200904420A/zh unknown
- 2008-05-08 CL CL2008001347A patent/CL2008001347A1/es unknown
- 2008-05-09 PE PE2008000822A patent/PE20090248A1/es not_active Application Discontinuation
- 2008-05-09 AR ARP080101972A patent/AR066509A1/es unknown
-
2009
- 2009-10-15 IL IL201566A patent/IL201566A/en active IP Right Grant
- 2009-10-28 ZA ZA200907585A patent/ZA200907585B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2358863T3 (es) | 2011-05-16 |
EP2155740B1 (en) | 2011-01-26 |
IL201566A (en) | 2013-08-29 |
AU2008250436B2 (en) | 2013-03-28 |
JP5264890B2 (ja) | 2013-08-14 |
AU2008250436A1 (en) | 2008-11-20 |
DE602008004769D1 (en) | 2011-03-10 |
KR20100008791A (ko) | 2010-01-26 |
CA2686754A1 (en) | 2008-11-20 |
US7910740B2 (en) | 2011-03-22 |
US20080280948A1 (en) | 2008-11-13 |
IL201566A0 (en) | 2010-05-31 |
ZA200907585B (en) | 2010-07-28 |
CA2686754C (en) | 2014-10-28 |
BRPI0811993A2 (pt) | 2014-11-18 |
WO2008138753A1 (en) | 2008-11-20 |
TW200904420A (en) | 2009-02-01 |
EP2155740A1 (en) | 2010-02-24 |
ATE496915T1 (de) | 2011-02-15 |
MX2009012163A (es) | 2009-12-01 |
CN101675045A (zh) | 2010-03-17 |
PE20090248A1 (es) | 2009-03-27 |
RU2009140182A (ru) | 2011-06-20 |
CL2008001347A1 (es) | 2009-05-29 |
KR101138045B1 (ko) | 2012-04-24 |
JP2010526847A (ja) | 2010-08-05 |
CN101675045B (zh) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066509A1 (es) | Derivados de tiazol, medicamentos que los contienen, proceso de preparacion y usos como moduladores de beta amiloide. | |
AR070395A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il- amina | |
AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek | |
AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
AR069849A1 (es) | Derivados de heteroarilo como antagonistas de receptor de orexina | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
AR077975A1 (es) | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina | |
PE20091818A1 (es) | DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
CL2010001486A1 (es) | Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak; composicion farmaceutica; kit farmaceutico; su uso en el tratamiento de enfermedades tales como cancer, diabetes, enfermedad de alzheimer, enfermedad hepatica, trastornos del snc, entre otras. | |
AR080177A1 (es) | Derivados de piperidina, un procedimiento para su preparacion, y su uso en medicamentos para el tratamiento de enfermedades mentales asociadas a la deposicion del beta-amiloide en el cerebro. | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
AR059328A1 (es) | Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp | |
ECSP099728A (es) | Compuestos amino-heterocíclicos | |
PE20160521A1 (es) | Inhibidores de autotaxina que comprenden un nucleo ciclico de anillo heteroaromatico-bencil-amida | |
MA37886B1 (fr) | Nouvelles pyridinones bicycliques | |
CU20090132A7 (es) | Compuestos tricíclicos, composiciones y procedimientos | |
AR078756A1 (es) | Moduladores alostericos positivos (map) | |
AR075583A1 (es) | Derivados de isoxazol/o-piridina con eslabon etilo o etenilo | |
PE20151001A1 (es) | Alcoxipirazoles como activadores de guanilato ciclasa soluble | |
AR065587A1 (es) | Aminoamidas como antagonistas de orexina | |
PE20091194A1 (es) | Derivados de heterociclicos como moduladores del receptor m1 | |
AR071925A1 (es) | Malonamidas como antagonistas de orexina | |
PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
AR076300A1 (es) | Derivados de pirimidin imidazoles sustituidos, inhibidores de gsk3, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento del alzheimer, enfermedades neurodegenerativas agudas, diabetes y otras enfermedades. | |
MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |